DE69821929D1 - Pharmazeutische zusammensetzung zur behandlung von parkinsonkrankheit oder depression - Google Patents

Pharmazeutische zusammensetzung zur behandlung von parkinsonkrankheit oder depression

Info

Publication number
DE69821929D1
DE69821929D1 DE69821929T DE69821929T DE69821929D1 DE 69821929 D1 DE69821929 D1 DE 69821929D1 DE 69821929 T DE69821929 T DE 69821929T DE 69821929 T DE69821929 T DE 69821929T DE 69821929 D1 DE69821929 D1 DE 69821929D1
Authority
DE
Germany
Prior art keywords
depression
disease
pharmaceutical composition
treating parkinson
vitamin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69821929T
Other languages
English (en)
Other versions
DE69821929T2 (de
Inventor
Keith Bridgeman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of DE69821929D1 publication Critical patent/DE69821929D1/de
Publication of DE69821929T2 publication Critical patent/DE69821929T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
DE69821929T 1997-01-28 1998-01-27 Pharmazeutische zusammensetzung zur behandlung von parkinsonkrankheit oder depression Expired - Lifetime DE69821929T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9701675.2A GB9701675D0 (en) 1997-01-28 1997-01-28 Composition for the treatment of parkinson's disease
GB9701675 1997-01-28
PCT/GB1998/000229 WO1998032464A1 (en) 1997-01-28 1998-01-27 Pharmaceutical composition comprising at least tyrosine and an iron compound for treating parkinson's disease or depression

Publications (2)

Publication Number Publication Date
DE69821929D1 true DE69821929D1 (de) 2004-04-01
DE69821929T2 DE69821929T2 (de) 2004-11-11

Family

ID=10806668

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69821929T Expired - Lifetime DE69821929T2 (de) 1997-01-28 1998-01-27 Pharmazeutische zusammensetzung zur behandlung von parkinsonkrankheit oder depression

Country Status (9)

Country Link
US (1) US6200607B1 (de)
EP (1) EP0980260B1 (de)
AT (1) ATE260117T1 (de)
AU (1) AU741511B2 (de)
DE (1) DE69821929T2 (de)
ES (1) ES2217534T3 (de)
GB (1) GB9701675D0 (de)
WO (1) WO1998032464A1 (de)
ZA (1) ZA98687B (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6476078B2 (en) * 1999-08-11 2002-11-05 Sepracor, Inc. Methods of using sibutramine metabolites in combination with a phosphodiesterase inhibitor to treat sexual dysfunction
EP0951842B1 (de) * 1999-01-20 2002-12-04 N.V. Nutricia Säuglingsnährpräparat
US7208180B2 (en) * 2000-05-08 2007-04-24 N.V. Nutricia Method and preparation for the preventing and/or treating vascular disorders and secondary disorders associated therewith
US7226916B1 (en) 2000-05-08 2007-06-05 N.V. Nutricia Preparation for the prevention and/or treatment of vascular disorders
US6620850B2 (en) * 2001-09-19 2003-09-16 University Of Florida Materials and methods for treatment of neurological disorders involving overactivation of glutamatergic ionotropic receptors
US20050065205A1 (en) 2002-03-07 2005-03-24 Daniel Alkon Methods for Alzheimer's disease treatment and cognitive enhance
US6825229B2 (en) 2002-03-07 2004-11-30 Blanchette Rockefeller Neurosciences Institute Methods for Alzheimer's Disease treatment and cognitive enhancement
GB0313630D0 (en) * 2003-06-12 2003-07-16 Wwk Trust The Compositions for the enhanced treatment of depression
TW201207390A (en) * 2004-05-18 2012-02-16 Brni Neurosciences Inst Method for screening agent for antidepressant activity
WO2007016202A1 (en) 2005-07-29 2007-02-08 Blanchette Rockefeller Neurosciences Institute Use of a pkc activator, alone or combined with a pkc inhibitor to enhance long term memory
US8367121B2 (en) * 2005-11-23 2013-02-05 Florida A & M University Nutraceutical agent for attenuating the neurodegenerative process associated with Parkinson's disease
CA2873179A1 (en) 2007-02-09 2008-08-21 Blanchette Rockefeller Neurosciences Institute Use of bryostatins and neristatins in the treatment of cognitive impairment due to head trauma
JP5098051B2 (ja) * 2007-04-05 2012-12-12 Ｓｂｉファーマ株式会社 ミトコンドリア障害脳疾患治療剤及び診断剤
US9463186B2 (en) 2013-04-15 2016-10-11 Northwestern University Treatment for dopaminergic disorders
EP3431491A1 (de) * 2017-07-18 2019-01-23 Centre National De La Recherche Scientifique Verfahren zur reinigung von proteinen mit einer tubulin-carboxypeptidase-aktivität und peptidbasierten inhibitoren davon
US11744833B2 (en) 2019-04-12 2023-09-05 LA PharmaTech Inc. Pharmaceutical compositions and methods for treatment of insomnia
US11690849B2 (en) 2019-04-12 2023-07-04 LA PharmaTech Inc. Method of treating dementia
US11351179B1 (en) 2021-08-05 2022-06-07 LA PharmaTech Inc. Pharmaceutical compositions and methods for treatment of psychiatric disorders

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4167564A (en) * 1974-09-23 1979-09-11 Albion Laboratories, Inc. Biological assimilation of metals
JPS58162515A (ja) * 1982-03-19 1983-09-27 Tanabe Seiyaku Co Ltd 末梢静脈注入用加電解質アミノ酸輸液
RO94381B1 (ro) * 1986-04-28 1988-05-01 Valentin Stroescu Produs medicamentos pentru sustinerea efortului de durata medie si lunga
FR2617711B1 (fr) * 1987-07-09 1991-01-04 Mouret Jacques Application de la l-tyrosine pour l'obtention de medicaments destines au traitement des deficits en dopamine dans les narcolepsies et les depressions dopamino-dependantes
US5122461A (en) * 1990-11-19 1992-06-16 Industrial Technology Research Institute Preparation of pyrocatecholic compounds
GB2268871A (en) * 1992-07-04 1994-01-26 Bio Nutritional Health Service Composition for use as a food or food supplement
JPH07330583A (ja) * 1994-06-03 1995-12-19 Terumo Corp 遊離型グルタミン酸を含有する液状製剤
GB9416921D0 (en) * 1994-08-22 1994-10-12 Conway Gitta C A nutritional preparation

Also Published As

Publication number Publication date
DE69821929T2 (de) 2004-11-11
US6200607B1 (en) 2001-03-13
ES2217534T3 (es) 2004-11-01
EP0980260B1 (de) 2004-02-25
AU5772598A (en) 1998-08-18
ATE260117T1 (de) 2004-03-15
GB9701675D0 (en) 1997-03-19
EP0980260A1 (de) 2000-02-23
WO1998032464A1 (en) 1998-07-30
ZA98687B (en) 1998-09-08
AU741511B2 (en) 2001-12-06

Similar Documents

Publication Publication Date Title
ATE260117T1 (de) Pharmazeutische zusammensetzung zur behandlung von parkinsonkrankheit oder depression
IS1907B (is) Notkun klóbindiefnisins klíókínól við að framleiða lyfjablöndu til að meðhöndla Alzheimers-sjúkdóm
DE60216830D1 (de) Pharmazeutische Zusammensetzungen zur Behandlung von Störungen des ZNS oder anderen Erkrankungen
MXPA03003960A (es) Combinaciones de farmacos (v.gr., clorpromazina y pentamidina) para el tratamiento de desordenes neoplasticos.
DE60134453D1 (de) Pharmazeutische Zusammensetzungen zur Behandlung von ZNS und anderen Krankheiten
ATE168560T1 (de) Topische mittel zur transdermalen verabreichung von prodrugderivaten des morphins
WO2003076003A3 (en) Method for modification of radiotherapy treatment delivery
HK1155944A1 (en) W-carboxy aryl substituted diphenyl ureas as p38 kinase inhibitors
NO960067D0 (no) Nytt farmasöytisk preparat
PT703786E (pt) Utilizacao de nonapeptideos e decapeptideos para a preparacao de um medicamento para o tratamento da sida
RS49599B (sr) Upotreba inhibitora h+, k+-atp-aze i glukokortikoida i farmaceutska formulacija
IT1222395B (it) Composizione farmaceutica per somministrazione intranasale comprendente l'ormone ghrh,un agonista colinergico e/o un sale biliare
PL367089A1 (en) Use of ginkgo biloba extracts for preparing a medicine for treating sarcopenia
HK1075654A1 (en) Hyperforin derivatives, the use thereof and formulations containing them
MEP5608A (xx) Nova upotreba (r) – (-)-2-[5-(4-fluorofenil)-3-piridil- metilaminometil] - hromana i njegovih fiziološko prihvatljivi h soli
BG103905A (en) New bpc peptide salts with organoprotective activity, method for their preparation and application in medicine
ATE380555T1 (de) Behandlung von autoimmunkrankheiten mit einem extrakt von amerikanischem ginseng
ATE147988T1 (de) Authentischen igf-1 und hypokalorische menge von nährstoffen enthaltendes produkt und dessen verwendung zur behandlung kataboler zustände
IL160160A0 (en) SUBSTITUTED 5,6,6a, 11b-TETRAHYDRO-7-OXA-5-AZA-BENZO[c]FLUORENE-6-CARBOXYLIC ACID DERIVATIVES SERVING AS NMDA ANTAGONISTS
MX9707949A (es) Peptido-2 semejante al glucagon y su uso terapeutico.
BR0005039A (pt) Antagonistas do receptor nk-1 e eletriptano para o tratamento da enxaqueca

Legal Events

Date Code Title Description
8364 No opposition during term of opposition